Carving out PBM services from a vertically integrated health company can be extremely difficult or cost-prohibitive and is anti-competitive, smaller PBMs argue. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
